Catalyst Wire Dossier Catalyst Wire Dossier

elvitegravir

elvitegravir · Gilead Sciences, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for elvitegravir, covering 2008-07-29 to 2019-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals [NA]

See pricing